首页> 外文OA文献 >Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

【2h】

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

机译：先前生物用法对患有中度至重度斑块牛皮癣患者的Brodalumab和Ustekumab的疗效和安全性的影响：随机对照试验Amagine-2和Amagine-3的综合分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
K.A. Papp; K.B. Gordon; R.G. Langley; M.G. Lebwohl; A.B. Gottlieb; S. Rastogi; R. Pillai; R.J. Israel;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE AMAGINE ‐2 and AMAGINE AMAGINE ‐3 [J] . Papp K.A., Gordon K.B., Langley R.G., British Journal of Dermatology . 2018,第2期

机译：先前生物用法对患有中度至重度斑块牛皮癣患者的Brodalumab和Ustekumab的疗效和安全的影响：随机对照试验Amagine Amagine -2和Amagine Amagine的综合分析-3
2. Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3) [J] . Blauvelt Andrew, Papp Kim A., Lebwohl Mark G., Journal of the American Academy of Dermatology . 2017,第2期

机译：用Brodalumab治疗中度至严重的牛皮癣患者的快速发作：来自两相3阶段随机临床试验的数据汇总分析（Amagine-2和Amagine-3）
3. Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials [J] . McMichael Amy, Desai Seemal R., Qureshi Aamir, Nature reviews neuroscience . 2019,第2期

机译：Brodalumab在中度至重度斑块牛皮癣和颜色皮肤患者中的疗效和安全性：汇集Amagine-2 / -3随机试验的结果
4. Impact of Complementary Therapies via Mobile Technologies on Icelandic Same Day Surgical Patients' Reports of Anxiety, Pain and Self-Efficacy in Healing: A Randomized Controlled Trial in Process [C] . Margaret M. Hansen MEDINFO . 2013

机译：互补疗法通过移动技术对冰岛同日外科患者的影响焦虑，痛苦和自我疗效愈合中的报告：过程中的随机对照试验
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Short-Term Efficacy and Safety of IL-17 IL-12/23 and IL-23 Inhibitors Brodalumab Secukinumab Ixekizumab Ustekinumab Guselkumab Tildrakizumab and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials [O] . Fan Bai, Gang Gang Li, Qingmin Liu, 2019

机译：IL-17IL-12 / 23和IL-23抑制剂BrodalumabSecukinumabIxekizumabUstekinumabGuselkumabTildrakizumab和Risankizumab治疗中度至重度斑块状牛皮癣的短期疗效和安全性：系统评价和随机对照试验的网络元分析
7. Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials [O] . Fan Bai, Gang Gang Li, Qingmin Liu, 2019

机译：IL-17，IL-12/23和IL-23抑制剂Brodalumab，Secukinumab，Ixekizumab，Ustekizumab，Guselkumab，Tildrakizumab和Risankizumab的短期疗效和安全性用于治疗中度至重度斑块牛皮癣：系统审查和随机对照试验的网络荟萃分析

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

著录项

引文网络

相似文献

相关主题

期刊订阅